Hunter Gillies, CHIEF MEDICAL OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 7,689 shares at $22.30 ($172K) on 2024-04-17, disclosed to the SEC on 2024-04-19.
Scheduled sale ($172k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.30 | 3,689 | $82K | 47.9% |
| 2 | $22.30 | 3,689 | $82K | 47.9% |
| 3 | $23.33 | 311 | $7K | 4.2% |
| Total | $22.34 avg | 7,689 | $172K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-01 | $266K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $346K | — | Filing → |
| AVTE | SELL | 2024-03-11 | $440K | — | Filing → |